A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma

NCT02157636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: CPI-0610

Sponsor

Constellation Pharmaceuticals

Collaborators

[object Object]